Cargando…
IMT-03 CLINICAL TRIAL FOR NEWLY DIAGNOSED MALIGNANT GLIOMA WITH WT1-W10 VACCINATION
OBJECT: Wilms’ tumor 1 (WT1) peptide vaccination is considered a potentially effective therapy against malignant glioma. We conducted a Phase I/II study to investigate the safety and feasibility of novel WT1 peptide (W10) vaccination therapy for patients with newly diagnosed malignant glioma. METHOD...
Autores principales: | Kawanishi, Yu, Udaka, Keiko, Yawata, Toshio, Nakai, Eiichi, Fukuda, Hitoshi, Fukui, Naoki, Ueba, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213291/ http://dx.doi.org/10.1093/noajnl/vdz039.078 |
Ejemplares similares
-
Elevated Cell Invasion in a Tumor Sphere Culture of RSV-M Mouse Glioma Cells
por: NONAKA, Motonobu, et al.
Publicado: (2015) -
MET-3 A Case of Intrapituitary Adenoma Metastasis from Advanced gastric cancer
por: Fujita, Shohei, et al.
Publicado: (2021) -
RONC-20. RECURRENT HIGH-GRADE ASTROBLASTOMA TREATED WITH STEREOTACTIC RADIOTHERAPY
por: Nishimoto, Shota, et al.
Publicado: (2020) -
IMT-05 PHASE III RANDOMIZED CLINICAL TRIAL OF AFTV FOR NEWLY DIAGNOSED GLIOBLASTOMA
por: Nitta, Masayuki, et al.
Publicado: (2019) -
Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors
por: Taniuchi, Keisuke, et al.
Publicado: (2019)